Stay updated with breaking news from Mark Swallow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- First clinical proof of concept data with lead OncoMimics therapeutic cancer vaccine candidate EO2401 expected in H1 2022 - New Corporate Identity and Website Launched Today PARIS
/PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its unique ability to decode the...
/PRNewswire/ -- Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumor membrane immunotherapy,...
Former Chair and CEO of Swedish Orphan Biovitrum brings a wealth of industry and leadership experience to Cytovation BERGEN, Norway, Oct. 27, 2021 /PRNewswire/ -- Cytovation AS, a clinical
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), the world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions...